Shannon Callan

Shannon Callan is an accomplished finance professional with extensive experience in accounting and SEC reporting. Currently serving as the Director of Accounting & SEC Reporting at Tarsus Pharmaceuticals, Inc. since August 2021, Shannon previously held the position of Associate Director, SEC Reporting & Corporate Accounting at Spectrum Pharmaceuticals, Inc., where responsibilities included managing the SEC Reporting function, corporate accounting for R&D, stock-based compensation, litigation accruals, and financial analysis. Earlier career roles included Sr. Accountant/Financial Analyst at Endologix Inc., Property Accountant at LBA Realty, and Experienced Associate at PwC. Shannon holds a Bachelor of Science in Business Administration with a focus in Accounting from California Polytechnic State University-San Luis Obispo.